<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01370382</url>
  </required_header>
  <id_info>
    <org_study_id>BOSCH2</org_study_id>
    <nct_id>NCT01370382</nct_id>
  </id_info>
  <brief_title>Comparison Between the New Highly Sensitive Troponin T and the Conventional Troponin T Test in Elderly Patients</brief_title>
  <acronym>BOSCH2</acronym>
  <official_title>Comparison Between the New Highly Sensitive Troponin T and the Conventional Troponin T Test of the 4th Generation for the Early Identification of Myocardial Necrosis in Elderly Patients With Acute Coronary Syndromes Without ST-segment Elevation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Klinikum Nürnberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The planned cohort study shall clarify whether the use of biomarkers leads to improved&#xD;
      diagnostic assessment of elderly patients. The study will evaluate the clinical value of&#xD;
      biomarkers (highly sensitive Troponin T, Troponin T of the 4th generation) in elderly&#xD;
      patients. These biomarkers are analyzed together with the symptoms and other parameters&#xD;
      collected at admission. The diagnosis of myocardial infarction could be made earlier and more&#xD;
      accurately with the help of biomarkers, in particular the highly sensitive troponin T.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All consecutive patients with acute symptoms and an age over 70 years will be recruited for&#xD;
      the study during 6 months. Medical history, physical examination, vital signs including heart&#xD;
      rate, blood pressure, body temperature, and any concomitant diseases are raised on admission&#xD;
      in the Emergency Department. Blood samples are taken for determination of routine laboratory.&#xD;
      Highly sensitive troponin T is determined as part of the routine. Troponin T is measured from&#xD;
      the same blood sample with a conventional test of the 4th generation. A second blood sample&#xD;
      is taken as part of routine 4-6 hours after the onset of symptoms to confirm or rule out any&#xD;
      acute coronary syndrome. Patients are divided according to the interval between the onset of&#xD;
      symptoms and presentation at the hospital in an &quot;early&quot;(&lt;4 hours) and &quot;late&quot;(&gt; = 4 hours)&#xD;
      group.&#xD;
&#xD;
      The Barthel Index as a geriatric assessment is raised. An electrocardiogram is written in all&#xD;
      patients at recording and evaluated. An echocardiographic examination is performed in all&#xD;
      patients for measurement of heart valve function, left ventricular diameter, ejection&#xD;
      fraction (LVEF) and diastolic function to differentiate into other mechanisms for the release&#xD;
      of troponin. According to the results of the echocardiographic examination, patients are&#xD;
      divided into sub-groups (LV-EF&gt; = 55%) and without preserved ejection fraction (LVEF &lt;55%).&#xD;
      The recording physician estimates after receiving the results of the investigations and&#xD;
      routine laboratory whether a myocardial infarction or heart failure is present. He&#xD;
      subsequently makes the decision about further treatment. The medical records will be&#xD;
      evaluated after completion of the stay in hospital by two experienced cardiologists, whether&#xD;
      a heart attack, heart failure or other disease was present. High sensitivity Troponin T and&#xD;
      Troponin T of the 4th generation are compared for the early and correct diagnosis of acute&#xD;
      coronary syndrome.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        1. Incidence of acute coronary syndromes without ST-segment elevation in elderly patients&#xD;
           by using the highly sensitive biomarker troponin T,&#xD;
&#xD;
        2. Comparison with the incidence of acute coronary syndromes without ST-segment elevation&#xD;
           in the same group by the use of troponin T of the 4th generation&#xD;
&#xD;
        3. Survey on differential diagnoses such as heart failure or other cardiac diseases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of acute coronary syndromes without ST-segment elevation during hospitalization.</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accurate diagnosis of myocardial infarction (without knowledge of biomarkers)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accurate diagnosis of acute heart failure (without knowledge of biomarkers)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Time interval</arm_group_label>
    <description>Patients are divided according to the interval between the onset of chest pain symptoms and presentation at the hospital in an &quot;early&quot;(&lt;4 hours) and &quot;late&quot;(&gt; = 4 hours) group.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Emergency department of the Klinikum Nürnberg (50,000 attendances per year; the department&#xD;
        caters to an urban population of approximately 1 million).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 70 or older&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hospitalization for unstable angina pectoris within the last 2 month&#xD;
&#xD;
          -  ST-segment elevation myocardial infarction&#xD;
&#xD;
          -  Heart valve defects with need for surgical intervention&#xD;
&#xD;
          -  Coronary bypass surgery or percutaneous transluminal angioplasty within the last 3&#xD;
             months&#xD;
&#xD;
          -  Planned elective coronary revascularization&#xD;
&#xD;
          -  Serum creatinine&gt; 2.0 mg / dl (177 µmol / liter)&#xD;
&#xD;
          -  Serum potassium&gt; 5.5 mmol / l Limited survival probability within the next 3 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp Bahrmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine II-2, Institute for Biomedicine of Ageing, Friedrich-Alexander-University Erlangen-Nürnberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum</name>
      <address>
        <city>Nürnberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Bahrmann P, Heppner HJ, Christ M, Bertsch T, Sieber C. Early detection of non-ST-elevation myocardial infarction in geriatric patients by a new high-sensitive cardiac troponin T assay. Aging Clin Exp Res. 2012 Jun;24(3):290-4. doi: 10.3275/7927. Epub 2011 Sep 26.</citation>
    <PMID>21952408</PMID>
  </results_reference>
  <results_reference>
    <citation>Bahrmann P, Christ M, Bahrmann A, Rittger H, Heppner HJ, Achenbach S, Bertsch T, Sieber CC. A 3-hour diagnostic algorithm for non-ST-elevation myocardial infarction using high-sensitivity cardiac troponin T in unselected older patients presenting to the emergency department. J Am Med Dir Assoc. 2013 Jun;14(6):409-16. doi: 10.1016/j.jamda.2012.12.005. Epub 2013 Jan 30.</citation>
    <PMID>23375478</PMID>
  </results_reference>
  <results_reference>
    <citation>Bahrmann P, Bahrmann A, Breithardt OA, Daniel WG, Christ M, Sieber CC, Bertsch T. Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department. Clin Chem Lab Med. 2013 Jun;51(6):1307-19. doi: 10.1515/cclm-2012-0401.</citation>
    <PMID>23314553</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 8, 2011</study_first_submitted>
  <study_first_submitted_qc>June 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2011</study_first_posted>
  <last_update_submitted>December 4, 2020</last_update_submitted>
  <last_update_submitted_qc>December 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Philipp Bahrmann</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>geriatrics</keyword>
  <keyword>troponin</keyword>
  <keyword>electrocardiography</keyword>
  <keyword>diagnosis</keyword>
  <keyword>myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

